U.S. Department of Health & Human Services
National Institutes of Health
NCATS
This repository is under review for potential modification in compliance with Administration directives.
Dismiss
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
MECBOTAMAB VEDOTIN
VF40YVX65F
Investigational
General
Names
7
Classification
2
Identifiers
6
Subunits
4
Related Substances
2
MECBOTAMAB VEDOTIN
VF40YVX65F
Investigational
General
Approval Year
Unknown
149,124
Names
7
Show
5
20
100
All
entries
Name
Type
Language
Name
Type
Language
BA-3011
Preferred Name
English
MECBOTAMAB VEDOTIN
Official Name
English
IMMUNOGLOBULIN G1 (DE-450-LYSINE), ANTI-(HUMAN TYROSINE KINASE RECEPTOR AXL) (HUMAN-MUS MUSCULUS MONOCLONAL BA301 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL BA301 .KAPPA.-CHAIN, DIMER, THIOETHER WITH N-(((4-((N-(6-(3-MERCAPTO-2,5-DIOXO
Common Name
English
MECBOTAMAB VEDOTIN [USAN]
Common Name
English
Mecbotamab vedotin [WHO-DD]
Common Name
English
Showing 1 to 5 of 7 entries
Previous
1
2
Next
Classification
2
Show
5
20
100
All
entries
Classification Tree
Code System
Code
Classification Tree
Code System
Code
Designated
ORPHAN DRUG
Designated
Treatment of pancreatic cancer
FDA ORPHAN DRUG
659718
Designated
ORPHAN DRUG
Designated
Treatment of Soft Tissue Sarcoma
FDA ORPHAN DRUG
802920
Showing 1 to 2 of 2 entries
Previous
1
Next
Identifiers
6
Show
5
20
100
All
entries
Code System
Code
Type
Description
Code System
Code
Type
Description
INN
11946
PRIMARY
SMS_ID
300000039973
PRIMARY
CAS
2460400-64-8
PRIMARY
NCI_THESAURUS
C156141
PRIMARY
USAN
JK-82
PRIMARY
Showing 1 to 5 of 6 entries
Previous
1
2
Next
Subunits
4
Subunit 0
>SUBUNIT_0
Subunit 1
>SUBUNIT_1
Subunit 2
>SUBUNIT_2
Subunit 3
>SUBUNIT_3
Related Substances
2
ACTIVE MOIETY
VF40YVX65F
MECBOTAMAB VEDOTIN
METABOLITE ACTIVE (PARENT)
V7I58RC5EJ
MONOMETHYL AURISTATIN E